Balchem Corp 8-K, filed Dec 16, 2021
Balchem Corp (BCPC)
8-K
2021-12-16
For: 2021-12-15
View Original
Added on
April 11, 2026
About this 8-K
Balchem Corp filed this 8-K on December 16, 2021, reporting on events of December 15, 2021.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED
STATES
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (date of earliest event reported): December 15, 2021
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
Registrant’s telephone number, including area code: (845 )
326-5600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|||
|
|
|
|
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01 |
Regulation FD Disclosure.
|
On December 16, 2021, Balchem Corporation (the “Company”) issued a press release announcing a dividend declared by the Company's Board of Directors
on December 15, 2021. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
| Item 9.01 |
Financial Statements and Exhibits.
|
(c) Exhibits
| Exhibit 99.1 |
Press Release of Balchem Corporation, dated December 16, 2021.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
BALCHEM CORPORATION
|
|||
|
By:/s/ Mark Stach
|
|||
|
Mark Stach, General Counsel and Secretary
|
|||
|
Dated: December 16, 2021
|
Exhibit 99.1
FOR IMMEDIATE RELEASE
Balchem Corporation Announces Dividend
New Hampton, New York. December 16, 2021. Balchem Corporation (NASDAQ: BCPC) today announced that on December 15, 2021, its Board of Directors declared a dividend on its shares of common stock equal to $0.64 per share on the Company’s issued and outstanding
Common Stock, to be payable on January 21, 2022 to stockholders of record at the close of business on December 28, 2021. This dividend represents an 10.3% increase over last year’s annual dividend.
Ted Harris, Balchem’s CEO and President, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of
that commitment. This dividend represents the thirteenth consecutive increase in our annual dividend, reflecting both the consistently outstanding financial performance the company has delivered and the Board’s continued confidence in our long-term
strategies.”
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet,
providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human
Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment
manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient
agricultural market.
Forward-Looking Statements
This release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties.
Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in
Balchem’s annual report on Form 10-K for the year ended December 31, 2020. Forward-looking statements are qualified in their entirety by
the above cautionary statement. Balchem assumes no duty to update its outlook or other
forward-looking statements as of any future date.
Contact: Danielle Polanco,
Executive and HR Assistant
Telephone: 845-326-5600
E-mail: dpolanco@balchem.com
2